Mirtazapine in L-dopa-induced dyskinesias

被引:0
|
作者
Fabrizio, E
Vanacore, N
Pratesi, L
Di Rezze, S
Alessandri, A
Meco, G
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P314
引用
收藏
页码:S107 / S107
页数:1
相关论文
共 50 条
  • [41] Reduction of L-DOPA-induced dyskinesias following intraventricular administration of GDNF in common marmosets
    Iravani, MM
    Costa, S
    Jackson, MJ
    Pearce, RKB
    Jenner, P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126
  • [42] EFFECT OF NONDOPAMINERGIC DRUGS ON L-DOPA-INDUCED DYSKINESIAS IN MPTP-TREATED MONKEYS
    GOMEZMANCILLA, B
    BEDARD, PJ
    [J]. CLINICAL NEUROPHARMACOLOGY, 1993, 16 (05) : 418 - 427
  • [43] Technological prospection: patents mapping involving compounds for the treatment of L-DOPA-induced dyskinesias
    Barroso, Sheilla Da Silva
    Sena Lopes, Lorenna Emilia
    Santos, Klebson Silva
    Gomes, Margarete Zanardo
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (12) : 979 - 985
  • [44] L-DOPA-INDUCED ASTERIXIS
    KOBAYASHI, I
    OSAWA, M
    OHTA, K
    MARUYAMA, S
    [J]. FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1985, 39 (04): : 507 - 513
  • [45] L-DOPA-induced dyskinesia
    Derkinderen, P
    Vidailhet, M
    [J]. REVUE NEUROLOGIQUE, 2002, 158 : S92 - S101
  • [46] New treatment (BN82451) and assessment for L-dopa-induced dyskinesias in parkinsonian macaques
    Badin, R. Aron
    Brouillet, E.
    Spinnewyn, B.
    Auguet, M.
    Chabrier, P. E.
    Hantraye, P.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S64 - S65
  • [47] Serotonergic mediated peak-dose L-DOPA-induced dyskinesias in Parkinson's disease
    Politis, M.
    Wu, K.
    Loane, C.
    Kiferle, L.
    Molloy, S.
    Bain, P.
    Brooks, D.
    Piccini, P.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S250 - S250
  • [48] New treatment (BN82451) and assessment for L-dopa-induced dyskinesias in hemiparkinsonian rats
    Spinnewyn, B.
    Rocher, M. N.
    Idrissi, M.
    Plas, P.
    Schmidlin, F.
    Ferrandis, E.
    Auguet, M.
    Chabrier, P. E.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S71 - S71
  • [49] Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias
    Gardoni, Fabrizio
    Sgobio, Carmelo
    Pendolino, Valentina
    Calabresi, Paolo
    Di Luca, Monica
    Picconi, Barbara
    [J]. NEUROBIOLOGY OF AGING, 2012, 33 (09) : 2138 - 2144
  • [50] 7-NITROINDAZOLE EFFECTS ON L-DOPA-INDUCED DYSKINESIAS AND ON STRIATAL NITRIC OXIDE PRODUCTION
    Padovan-Neto, F. E.
    Romano, A. C.
    Ferreira, F.
    Del Bel, E. A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 47 - 47